The Role of IL-6 in Inflammatory Diseases CME/CE
Bernard Rubin, DO, MPH; Gary S. Firestein, MD; Leonard H. Calabrese, DO Author Information and Disclosures
Release Date: June 4, 2007; Valid for credit through June 4, 2008
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs) |
 |
This program will provide clinicians with a basic understanding of the role of interleukin-6 (IL-6) in the pathogenesis of inflammatory disease with a particular focus on its actions in the initiation, ongoing joint damage, and systemic manifestations associated with rheumatoid arthritis (RA). A description of how IL-6 participates in the inflammatory cascade will be provided and the importance of both the membrane-bound and soluble IL-6 receptor for targeting cells will be emphasized. Preliminary clinical data from trials of a humanized monoclonal antibody directed against the IL-6 receptor in patients with RA will be presented and the efficacy and safety of this approach to the treatment of RA evaluated.
Participants have the opportunity to view this roundtable discussion in a slides & video format.
Contents of This CME/CE Activity
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2007 Interquest Medical & Scientific Communications, LLC and University of Virginia School of Medicine.
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.00 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education.